Skip to main content

Table 3 Comparison between the studied groups as regard plasma PTX3 (ng/mL)

From: Pentraxin-3 in non-alcoholic fatty liver disease and its affection by concomitant chronic hepatitis C infection

GroupNMean ± SDRangePercentilesp value between three groupsp value between groups I and II
25th50th (median)75th
Group Ι
 NAFLD patients
255.5 ± 4.90.3–202.54.06.6< 0.001a0.5b
Group ΙΙ
 NAFLD patients with HCV
255.8 ± 4.50.3–213.04.58.0
Group ΙΙΙ
 Healthy control
200.9 ± 0.50.2–2.10.50.91.2
  1. HCV hepatitis C virus, NAFLD nonalcoholic fatty liver disease
  2. aKruskal-Wallis test is statistically significant at 95% confidence level
  3. bMann-Whitney test is statistically significant at 95% confidence level